Omnicell

Omnicell

Yahoo Finance • 30 days ago

3 Healthcare Stocks We Think Twice About

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destocking have persisted in the wake of COVID-19, limiting growth. This has capped... Full story

Yahoo Finance • last month

Healthcare Technology for Providers Stocks Q1 Earnings: Omnicell (NASDAQ:OMCL) Best of the Bunch

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology for providers industry, including Omnicell (NASDAQ:OMCL) and its peers. The healthcare technology... Full story

Yahoo Finance • last month

3 Reasons to Avoid OMCL and 1 Stock to Buy Instead

Omnicell’s 23% return over the past six months has outpaced the S&P 500 by 13%, and its stock price has climbed to $43.73 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating thei... Full story

Yahoo Finance • last month

Here is What Analysts Are Saying About Omnicell, Inc. (OMCL)

Omnicell, Inc. (NASDAQ:OMCL) is one of the best small cap stocks to buy for 10x potential. Omnicell, Inc. (NASDAQ:OMCL) received several rating updates following the release of its financial results for fiscal Q1 2026 on April 28. Craig-Ha... Full story

Yahoo Finance • 2 months ago

Investment Advisor Sells $6.6 Million Worth of Medical Solutions Stock, According to Recent SEC Filing

Key Points Avory & Company, LLC sold 156,571 shares of Omnicell; estimated trade value was $6.55 million based on quarterly average pricing The quarter-end value of the Omnicell position fell by $8.01 million, reflecting both the share sa... Full story

Yahoo Finance • 2 months ago

Smart Pill Dispenser Market Forecast Report 2025-2031: Omnicell, Capsa Healthcare and Becton Dickinson Strengthen Home Care Medication Management Market with Institutional and Delivery Expertise

Company Logo The smart pill dispenser market offers growth opportunities driven by technological advancements, IoT connectivity, and healthcare integration. Key opportunities include enhancing medication adherence, reducing costs from non... Full story

Yahoo Finance • 3 months ago

Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as investors reacted to escalating uncertainty tied to the U.S.-Iran conflict and poli... Full story

Yahoo Finance • 4 months ago

Omnicell, Inc. (OMCL): A Bull Case Theory

We came across a bullish thesis on Omnicell, Inc. on Danny’s Substack by Danny Green. In this article, we will summarize the bulls’ thesis on OMCL. Omnicell, Inc.'s share was trading at $38.61 as of February 18th. OMCL’s trailing P/E was 9... Full story

Yahoo Finance • 7 months ago

Announcing Omnicell Titan XT, the Next Generation, Automated Dispensing System Designed to Empower Autonomous Medication Management

Powered by OmniSphere, Titan XT is built to support evolving healthcare needs while delivering greater pharmacy control and nursing confidence for a growing enterprise FORT WORTH, Texas, December 08, 2025--(BUSINESS WIRE)--Omnicell, Inc.... Full story

Yahoo Finance • 7 months ago

Medication Adherence Research Report 2025: Market to Reach $3.63 Billion by 2030, Driven by Rising Chronic Disease Burden, Aging Populations, and Growing Adoption of Digital Health Tools

Company Logo The Global Medication Adherence Market presents opportunities driven by the rising prevalence of chronic diseases, an aging population, and healthcare tech advances, notably AI integration. Challenges include high medication... Full story

Yahoo Finance • 8 months ago

Omnicell outlines raised 2025 revenue guidance to $1.177B-$1.187B as cloud platform gains traction

Earnings Call Insights: Omnicell (OMCL) Q3 2025 MANAGEMENT VIEW * Randall Lipps, Founder, Executive Chairman, President & CEO, announced "another strong quarter" for Omnicell, highlighting that "total revenues, non-GAAP EBITDA and non-... Full story

Yahoo Finance • 9 months ago

Myriad Genetics, Omnicell, Globus Medical, Repligen, and Teleflex Stocks Trade Down, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. The president's tone and the suggestion of canceling... Full story

Yahoo Finance • 9 months ago

Implied FYX Analyst Target Price: $122

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied... Full story

Yahoo Finance • 10 months ago

Evoke Pharma and EVERSANA Expand GIMOTI® Access to Gastro Health and Other Large GI Practices through Omnicell Relationship

Separately Secures Access to OneGI Through Brentwood Pharmacy Agreement Gimoti Specialty Pharmacy Network to Almost Double with Additional Relationships SOLANA BEACH, Calif. and CHICAGO, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma,... Full story

Yahoo Finance • 10 months ago

Omnicell appoints Baird Radford as Executive VP and CFO

* Omnicell (NASDAQ:OMCL [https://seekingalpha.com/symbol/OMCL]) announced on Monday the appointment [https://seekingalpha.com/pr/20210694-omnicell-appoints-baird-radford-as-executive-vice-president-and-chief-financial-officer] of Baird R... Full story

Yahoo Finance • 10 months ago

AI in Endoscopy: Industry Outlook Through 2025-2029 Featuring Strategic Analysis of 13 Market Players in Hospitals, Specialty Clinics, and ASCs

Dublin, Aug. 19, 2025 (GLOBE NEWSWIRE) -- The "AI in Endoscopy Market 2025-2029" has been added to ResearchAndMarkets.com's offering. The AI in endoscopy market is projected to expand by USD 2.56 billion from 2024 to 2029, exhibiting a... Full story

Yahoo Finance • 11 months ago

Piper Sandler lowers Omnicell stock price target to $55 on tariff concerns

Investing.com - Piper Sandler reduced its price target on Omnicell (NASDAQ:OMCL) to $55.00 from $57.00 on Monday, while maintaining an Overweight rating on the healthcare technology company. Currently trading at $30.83, the stock remains... Full story

Yahoo Finance • 11 months ago

Wells Fargo raises Omnicell stock price target to $40 on reduced tariff impact

Investing.com - Wells Fargo raised its price target on Omnicell (NASDAQ:OMCL) to $40.00 from $37.00 on Monday, while maintaining an Overweight rating on the stock, citing a more favorable tariff outlook. Currently trading at $26.88 with... Full story

Yahoo Finance • 11 months ago

Benchmark reiterates Buy rating on Omnicell stock amid tariff uncertainties

Investing.com - Benchmark has reiterated its Buy rating and $40.00 price target on Omnicell (NASDAQ:OMCL), currently trading at $27.82, as the company navigates through tariff uncertainties with China. According to InvestingPro data, ana... Full story

Yahoo Finance • 11 months ago

MeridianLink Appoints Tech Veteran Denise Cox as Chief Customer Officer

MeridianLink Appoints Tech Veteran Denise Cox as Chief Customer Officer Cox will lead MeridianLink’s Services, Support and Customer Success teams to strengthen customer relationships and experience IRVINE, Calif., July 15, 2025--(BUSINES... Full story